Activist investor Ancora Holdings secures two board seats at Elanco Animal Health in a settlement.

Activist investor Ancora Holdings has secured two board seats at Elanco Animal Health, as per a settlement between the two parties, avoiding a proxy fight. Elanco will add Ancora nominees Craig Wallace and Kathy Turner to its board, while CEO Jeff Simmons will retain his position. Ancora previously sought four board seats and a CEO replacement due to concerns over the company's performance.